Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Cognition, Health-Related Quality of Life, and Depression Ten Years after Moderate to Severe Traumatic Brain Injury: A Prospective Cohort Study.

Grauwmeijer E, Heijenbrok-Kal MH, Peppel LD, Hartjes CJ, Haitsma IK, de Koning I, Ribbers GM.

J Neurotrauma. 2018 Jul 1;35(13):1543-1551. doi: 10.1089/neu.2017.5404. Epub 2018 Apr 6.

PMID:
29343203
2.

Validating the WHO maternal near miss tool: comparing high- and low-resource settings.

Witteveen T, Bezstarosti H, de Koning I, Nelissen E, Bloemenkamp KW, van Roosmalen J, van den Akker T.

BMC Pregnancy Childbirth. 2017 Jun 19;17(1):194. doi: 10.1186/s12884-017-1370-0.

3.

Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study.

Dopper EG, Chalos V, Ghariq E, den Heijer T, Hafkemeijer A, Jiskoot LC, de Koning I, Seelaar H, van Minkelen R, van Osch MJ, Rombouts SA, van Swieten JC.

Neuroimage Clin. 2016 Aug 3;12:460-5. doi: 10.1016/j.nicl.2016.08.001. eCollection 2016.

4.

Functional connectivity and microstructural white matter changes in phenocopy frontotemporal dementia.

Meijboom R, Steketee RM, de Koning I, Osse RJ, Jiskoot LC, de Jong FJ, van der Lugt A, van Swieten JC, Smits M.

Eur Radiol. 2017 Apr;27(4):1352-1360. doi: 10.1007/s00330-016-4490-4. Epub 2016 Jul 19.

5.

Structural and functional brain abnormalities place phenocopy frontotemporal dementia (FTD) in the FTD spectrum.

Steketee RME, Meijboom R, Bron EE, Osse RJ, de Koning I, Jiskoot LC, Klein S, de Jong FJ, van der Lugt A, van Swieten JC, Smits M.

Neuroimage Clin. 2016 Apr 10;11:595-605. doi: 10.1016/j.nicl.2016.03.019. eCollection 2016.

6.

Validating the WHO Maternal Near Miss Tool in a high-income country.

Witteveen T, de Koning I, Bezstarosti H, van den Akker T, van Roosmalen J, Bloemenkamp KW.

Acta Obstet Gynecol Scand. 2016 Jan;95(1):106-11. doi: 10.1111/aogs.12793. Epub 2015 Oct 26.

PMID:
26456014
7.

Assessment methods and prevalence of cognitive dysfunction in patients with low-grade glioma: A systematic review.

van Loon EM, Heijenbrok-Kal MH, van Loon WS, van den Bent MJ, Vincent AJ, de Koning I, Ribbers GM.

J Rehabil Med. 2015 Jun;47(6):481-8. doi: 10.2340/16501977-1975. Review.

8.

Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia.

Dopper EG, Rombouts SA, Jiskoot LC, den Heijer T, de Graaf JR, de Koning I, Hammerschlag AR, Seelaar H, Seeley WW, Veer IM, van Buchem MA, Rizzu P, van Swieten JC.

Neurology. 2014 Jul 8;83(2):e19-26. doi: 10.1212/WNL.0000000000000583.

PMID:
25002573
9.

Cerebral small vessel disease affects white matter microstructure in mild cognitive impairment.

Papma JM, de Groot M, de Koning I, Mattace-Raso FU, van der Lugt A, Vernooij MW, Niessen WJ, van Swieten JC, Koudstaal PJ, Prins ND, Smits M.

Hum Brain Mapp. 2014 Jun;35(6):2836-51. doi: 10.1002/hbm.22370. Epub 2013 Sep 23.

PMID:
24115179
10.

Episodic memory impairment in frontotemporal dementia; a ⁹⁹mTc- HMPAO SPECT study.

Papma JM, Seelaar H, de Koning I, Hasan D, Reijs A, Valkema R, Prins ND, van Swieten JC.

Curr Alzheimer Res. 2013 Mar;10(3):332-9.

PMID:
23016870
11.

Midcingulate involvement in progressive supranuclear palsy and tau positive frontotemporal dementia.

Chiu WZ, Papma JM, de Koning I, Donker Kaat L, Seelaar H, Reijs AE, Valkema R, Hasan D, Boon AJ, van Swieten JC.

J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):910-5. doi: 10.1136/jnnp-2011-302035. Epub 2012 Jun 25.

PMID:
22733085
12.

The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.

Simón-Sánchez J, Dopper EG, Cohn-Hokke PE, Hukema RK, Nicolaou N, Seelaar H, de Graaf JR, de Koning I, van Schoor NM, Deeg DJ, Smits M, Raaphorst J, van den Berg LH, Schelhaas HJ, De Die-Smulders CE, Majoor-Krakauer D, Rozemuller AJ, Willemsen R, Pijnenburg YA, Heutink P, van Swieten JC.

Brain. 2012 Mar;135(Pt 3):723-35. doi: 10.1093/brain/awr353. Epub 2012 Feb 1.

PMID:
22300876
13.

The influence of cerebral small vessel disease on default mode network deactivation in mild cognitive impairment.

Papma JM, den Heijer T, de Koning I, Mattace-Raso FU, van der Lugt A, van der Lijn F, van Swieten JC, Koudstaal PJ, Smits M, Prins ND.

Neuroimage Clin. 2012 Nov 16;2:33-42. doi: 10.1016/j.nicl.2012.11.005. eCollection 2012.

14.

Symmetrical corticobasal syndrome caused by a novel C.314dup progranulin mutation.

Dopper EG, Seelaar H, Chiu WZ, de Koning I, van Minkelen R, Baker MC, Rozemuller AJ, Rademakers R, van Swieten JC.

J Mol Neurosci. 2011 Nov;45(3):354-8. doi: 10.1007/s12031-011-9626-z. Epub 2011 Aug 24.

15.

Brain perfusion patterns in familial frontotemporal lobar degeneration.

Seelaar H, Papma JM, Garraux G, de Koning I, Reijs AE, Valkema R, Rozemuller AJ, Salmon E, van Swieten JC.

Neurology. 2011 Jul 26;77(4):384-92. doi: 10.1212/WNL.0b013e3182270456. Epub 2011 Jul 13.

PMID:
21753175
16.

Genetic risk factors for cerebral small-vessel disease in hypertensive patients from a genetically isolated population.

Schuur M, van Swieten JC, Schol-Gelok S, Ikram MA, Vernooij MW, Liu F, Isaacs A, de Boer R, de Koning I, Niessen WJ, Vrooman H, Oostra BA, van der Lugt A, Breteler MM, van Duijn CM.

J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):41-4. doi: 10.1136/jnnp.2009.176362. Epub 2010 Jul 28.

PMID:
20667857
17.

Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study.

Schuur M, Henneman P, van Swieten JC, Zillikens MC, de Koning I, Janssens AC, Witteman JC, Aulchenko YS, Frants RR, Oostra BA, van Dijk KW, van Duijn CM.

Eur J Epidemiol. 2010 Aug;25(8):561-8. doi: 10.1007/s10654-010-9476-y. Epub 2010 Jun 29.

18.

Clinical features and X-inactivation in females heterozygous for creatine transporter defect.

van de Kamp JM, Mancini GM, Pouwels PJ, Betsalel OT, van Dooren SJ, de Koning I, Steenweg ME, Jakobs C, van der Knaap MS, Salomons GS.

Clin Genet. 2011 Mar;79(3):264-72. doi: 10.1111/j.1399-0004.2010.01460.x.

PMID:
20528887
19.

Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration.

Seelaar H, Klijnsma KY, de Koning I, van der Lugt A, Chiu WZ, Azmani A, Rozemuller AJ, van Swieten JC.

J Neurol. 2010 May;257(5):747-53. doi: 10.1007/s00415-009-5404-z. Epub 2009 Nov 28.

20.

Adaptive cognitive testing in cerebrovascular disease and vascular dementia.

Wouters H, de Koning I, Zwinderman AH, van Gool WA, Schmand B, Buiter M, Lindeboom R.

Dement Geriatr Cogn Disord. 2009;28(5):486-92. doi: 10.1159/000250593. Epub 2009 Nov 27.

PMID:
19940481
21.

Neuropsychological assessment: sense and sensibility.

de Koning I.

Stroke. 2009 Sep;40(9):2949-50. doi: 10.1161/STROKEAHA.109.556050. Epub 2009 Jul 9. No abstract available.

PMID:
19590050
22.

A study of the SORL1 gene in Alzheimer's disease and cognitive function.

Liu F, Ikram MA, Janssens AC, Schuur M, de Koning I, Isaacs A, Struchalin M, Uitterlinden AG, den Dunnen JT, Sleegers K, Bettens K, Van Broeckhoven C, van Swieten J, Hofman A, Oostra BA, Aulchenko YS, Breteler MM, van Duijn CM.

J Alzheimers Dis. 2009;18(1):51-64. doi: 10.3233/JAD-2009-1137.

PMID:
19584446
23.

Association of cognitive functioning with retinal nerve fiber layer thickness.

van Koolwijk LM, Despriet DD, Van Duijn CM, Oostra BA, van Swieten JC, de Koning I, Klaver CC, Lemij HG.

Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4576-80. doi: 10.1167/iovs.08-3181. Epub 2009 May 6.

PMID:
19420335
24.

The apolipoprotein E gene and its age-specific effects on cognitive function.

Liu F, Pardo LM, Schuur M, Sanchez-Juan P, Isaacs A, Sleegers K, de Koning I, Zorkoltseva IV, Axenovich TI, Witteman JC, Janssens AC, van Swieten JC, Aulchenko YS, Oostra BA, van Duijn CM.

Neurobiol Aging. 2010 Oct;31(10):1831-3. doi: 10.1016/j.neurobiolaging.2008.09.015. Epub 2008 Nov 11.

PMID:
19004527
25.

Distinct genetic forms of frontotemporal dementia.

Seelaar H, Kamphorst W, Rosso SM, Azmani A, Masdjedi R, de Koning I, Maat-Kievit JA, Anar B, Donker Kaat L, Breedveld GJ, Dooijes D, Rozemuller JM, Bronner IF, Rizzu P, van Swieten JC.

Neurology. 2008 Oct 14;71(16):1220-6. doi: 10.1212/01.wnl.0000319702.37497.72. Epub 2008 Aug 13.

PMID:
18703462
26.

The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis.

Siepman TA, Janssens AC, de Koning I, Polman CH, Boringa JB, Hintzen RQ.

J Neurol. 2008 Jun;255(6):910-6. doi: 10.1007/s00415-008-0814-x. Epub 2008 May 20.

PMID:
18484237
27.

CSF biomarkers in frontotemporal lobar degeneration with known pathology.

Bian H, Van Swieten JC, Leight S, Massimo L, Wood E, Forman M, Moore P, de Koning I, Clark CM, Rosso S, Trojanowski J, Lee VM, Grossman M.

Neurology. 2008 May 6;70(19 Pt 2):1827-35. doi: 10.1212/01.wnl.0000311445.21321.fc.

28.

Impaired maternal cognitive functioning after pregnancies complicated by severe pre-eclampsia: a pilot case-control study.

Brussé I, Duvekot J, Jongerling J, Steegers E, De Koning I.

Acta Obstet Gynecol Scand. 2008;87(4):408-12. doi: 10.1080/00016340801915127.

PMID:
18382865
29.

Post-stroke dementia and depression: frontosubcortical dysfunction as missing link?

Naarding P, de Koning I, van Kooten F, Janzing JG, Beekman AT, Koudstaal PJ.

Int J Geriatr Psychiatry. 2007 Jan;22(1):1-8.

PMID:
17117393
30.

Cerebrovascular risk factors do not contribute to genetic variance of cognitive function: the ERF study.

Sleegers K, de Koning I, Aulchenko YS, van Rijn MJ, Houben MP, Croes EA, van Swieten JC, Oostra BA, van Duijn CM.

Neurobiol Aging. 2007 May;28(5):735-41. Epub 2006 May 12.

PMID:
16698126
31.

Spinocerebellar ataxia associated with a mutation in the fibroblast growth factor 14 gene (SCA27): A new phenotype.

Brusse E, de Koning I, Maat-Kievit A, Oostra BA, Heutink P, van Swieten JC.

Mov Disord. 2006 Mar;21(3):396-401.

PMID:
16211615
32.

Diagnostic value of the Rotterdam-CAMCOG in post-stroke dementia.

de Koning I, van Kooten F, Koudstaal PJ, Dippel DW.

J Neurol Neurosurg Psychiatry. 2005 Feb;76(2):263-5.

33.

Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study.

Rosso SM, Donker Kaat L, Baks T, Joosse M, de Koning I, Pijnenburg Y, de Jong D, Dooijes D, Kamphorst W, Ravid R, Niermeijer MF, Verheij F, Kremer HP, Scheltens P, van Duijn CM, Heutink P, van Swieten JC.

Brain. 2003 Sep;126(Pt 9):2016-22. Epub 2003 Jul 22.

PMID:
12876142
34.

Depression in vascular dementia.

Naarding P, de Koning I, dan Kooten F, Dippel DW, Janzing JG, van der Mast RC, Koudstaal PJ.

Int J Geriatr Psychiatry. 2003 Apr;18(4):325-30.

PMID:
12673609
35.

A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected].

van Swieten JC, Brusse E, de Graaf BM, Krieger E, van de Graaf R, de Koning I, Maat-Kievit A, Leegwater P, Dooijes D, Oostra BA, Heutink P.

Am J Hum Genet. 2003 Jan;72(1):191-9. Epub 2002 Dec 13. Erratum in: Am J Hum Genet. 2003 Apr;72(4):1078.

36.

Complex compulsive behaviour in the temporal variant of frontotemporal dementia.

Rosso SM, Roks G, Stevens M, de Koning I, Tanghe HLJ, Kamphorst W, Ravid R, Niermeijer MF, van Swieten JC.

J Neurol. 2001 Nov;248(11):965-70.

PMID:
11757960
37.

Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692).

Roks G, Van Harskamp F, De Koning I, Cruts M, De Jonghe C, Kumar-Singh S, Tibben A, Tanghe H, Niermeijer MF, Hofman A, Van Swieten JC, Van Broeckhoven C, Van Duijn CM.

Brain. 2000 Oct;123 ( Pt 10):2130-40.

PMID:
11004129
38.

A short screening instrument for poststroke dementia : the R-CAMCOG.

de Koning I, Dippel DW, van Kooten F, Koudstaal PJ.

Stroke. 2000 Jul;31(7):1502-8.

PMID:
10884444
39.

Frontotemporal dementia and neuropsychology: the value of missing values.

Smeding HM, de Koning I.

J Neurol Neurosurg Psychiatry. 2000 Jun;68(6):726-30.

40.

Phenotypic variation in hereditary frontotemporal dementia with tau mutations.

van Swieten JC, Stevens M, Rosso SM, Rizzu P, Joosse M, de Koning I, Kamphorst W, Ravid R, Spillantini MG, Niermeijer, Heutink P.

Ann Neurol. 1999 Oct;46(4):617-26.

PMID:
10514099
41.

Value of screening instruments in the diagnosis of post-stroke dementia.

de Koning I, van Kooten F, Koudstaal PJ.

Haemostasis. 1998 May-Aug;28(3-4):158-66. Review.

PMID:
10420063
42.

The CAMCOG: a useful screening instrument for dementia in stroke patients.

de Koning I, van Kooten F, Dippel DW, van Harskamp F, Grobbee DE, Kluft C, Koudstaal PJ.

Stroke. 1998 Oct;29(10):2080-6.

PMID:
9756586
43.

Risk of left ventricular dysfunction in patients with probable Alzheimer's disease with APOE*4 allele.

van der Cammen TJ, Verschoor CJ, van Loon CP, van Harskamp F, de Koning I, Schudel WJ, Slooter AJ, Van Broeckhoven C, van Duijn CM.

J Am Geriatr Soc. 1998 Aug;46(8):962-7.

PMID:
9706883
44.

Abnormal amino acid metabolism in patients with early stage Alzheimer dementia.

Fekkes D, van der Cammen TJ, van Loon CP, Verschoor C, van Harskamp F, de Koning I, Schudel WJ, Pepplinkhuizen L.

J Neural Transm (Vienna). 1998;105(2-3):287-94.

PMID:
9660107
45.

Lisuride treatment of Alzheimer's disease. A preliminary placebo-controlled clinical trial of safety and therapeutic efficacy.

Claus JJ, de Koning I, van Harskamp F, Breteler MM, Voet B, Gutzmann H, Dahlke F, van der Cammen T, Hofman A.

Clin Neuropharmacol. 1998 May-Jun;21(3):190-5.

PMID:
9617511
46.

Slowly progressive isolated dysarthria: longitudinal course, speech features, and neuropsychological deficits.

de Koning I, van Doorn PA, van Dongen HR.

J Neurol. 1997 Oct;244(10):664-6. No abstract available.

PMID:
9402545
47.

The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study.

Claus JJ, van Harskamp F, Breteler MM, Krenning EP, de Koning I, van der Cammen TJ, Hofman A, Hasan D.

Neurology. 1994 Mar;44(3 Pt 1):454-61.

PMID:
8145915

Supplemental Content

Loading ...
Support Center